About SSI Diagnostica
SSI Diagnostica is a company based in Hillerød (Denmark) founded in 2016 was acquired by Adelis Equity Partners in March 2016. SSI Diagnostica has completed 2 acquisitions, including CTK Biotech and TECHLAB.
- Headquarter Hillerød, Denmark
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$44.77 M (USD)-40as on Dec 31, 2022
-
Net Profit
$16.39 M (USD)-56as on Dec 31, 2022
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
CTK Biotech
& 1 more
-
Acquired by
Adelis Equity Partners
(Mar 30, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of SSI Diagnostica
Unlock access to complete
Unlock access to complete
Funding Insights of SSI Diagnostica
Detailed funding history for SSI Diagnostica
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in SSI Diagnostica
SSI Diagnostica has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Adelis Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Adelis Equity is engaged in growing Nordic businesses through partnerships.
|
Locked | Locked | Locked |
Investor details for SSI Diagnostica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SSI Diagnostica
SSI Diagnostica has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CTK Biotech and TECHLAB.
Investment portfolio details for SSI Diagnostica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Lateral flow immunoassay and ELISA kits for clinical diagnostics
|
Locked | Locked | 1997 | Locked | |
|
Rapid diagnostic tests for gastrointestinal diseases are developed and manufactured.
|
Locked | Locked | 1989 | Locked |
Complete acquisition details for SSI Diagnostica
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SSI Diagnostica
Detailed financials for SSI Diagnostica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ssi Diagnostica Comparisons
Peer comparison for SSI Diagnostica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SSI Diagnostica
Detailed competitors of SSI Diagnostica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ssi Diagnostica
Complete news archive for SSI Diagnostica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SSI Diagnostica
SSI Diagnostica was founded in 2016.
SSI Diagnostica is headquartered in Hillerød, Denmark. It is registered at Hillerød, Capital Region, Denmark.
Soren Skjold Mogensen is the current CEO of SSI Diagnostica.
Annual revenue of SSI Diagnostica is $44.77M as on Dec 31, 2022.
SSI Diagnostica was founded in 2016 and is based in Hillerod, Denmark. Operations focus on the production of diagnostic kits and quality control testing solutions within the healthcare sector. These products support laboratory and clinical testing needs. The company is led by CEO Soren Skjold Mogensen, with activities centered on European markets.
SSI Diagnostica has made 2 acquisitions, including CTK Biotech, and TECHLAB.
SSI Diagnostica has 1 investor. Key investors include Adelis Equity.